share_log

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $105 Price Target

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $105 Price Target

HC Wainwright & Co.重申买入Praxis Precision Medicine,维持105美元的目标股价
Benzinga ·  04/26 07:06

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $105 price target.

HC Wainwright & Co. 分析师曹道格拉斯重申了Praxis精准医学(纳斯达克股票代码:PRAX)的买入并维持105美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发